Skip to main content
logo
BioPharma Credit PLC (LON:BPCR)
London flag London · Delayed Price · Currency is GBP · Price in USD
0.9760
+0.0060 (0.62%)
Oct 15, 2026, 2:12 PM GMT

BioPharma Credit Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Other Revenue
131.4157.75150.03135.74218.17103.88
Revenue
131.4157.75150.03135.74218.17103.88
Revenue Growth
-15.04%5.14%10.53%-37.78%110.02%-5.58%
Gross Profit
131.4157.75150.03135.74218.17103.88
Selling, General & Admin
23.9228.0327.7227.2835.7918.95
Other Operating Expenses
-0.01-0.140.1300.04-0.05
Operating Expenses
23.9127.927.8527.2835.8318.9
Operating Income
107.49129.85122.18108.46182.3484.98
Interest Expense
-0-----
Currency Exchange Gain (Loss)
0.010.04-0-0.01-0.03-0.02
Pretax Income
107.49129.89122.18108.45182.3184.96
Net Income
107.49129.89122.18108.45182.3184.96
Net Income to Common
107.49129.89122.18108.45182.3184.96
Net Income Growth
-12.70%6.31%12.66%-40.51%114.59%-4.69%
Shares Outstanding (Basic)
1,1281,1401,2221,3091,3641,374
Shares Outstanding (Diluted)
1,1281,1401,2221,3091,3641,374
Shares Change
-3.96%-6.77%-6.65%-4.00%-0.72%-0.00%
EPS (Basic)
0.100.110.100.080.130.06
EPS (Diluted)
0.100.110.100.080.130.06
EPS Growth
-9.10%14.03%20.68%-38.03%116.14%-4.68%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.0700.0700.0700.0700.0700.070
Dividend Growth
0%0%0%0%0%0%
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
81.80%82.31%81.44%79.90%83.58%81.80%
Profit Margin
81.81%82.34%81.44%79.90%83.56%81.79%
EBIT
107.49129.85122.18108.46182.3484.98
EBIT Margin
81.80%82.31%81.44%79.90%83.58%81.80%
Revenue as Reported
131.4157.78150.03135.73218.14103.86